These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 30048894)

  • 21. Normal phase and reverse phase HPLC-UV-MS analysis of process impurities for rapamycin analog ABT-578: application to active pharmaceutical ingredient process development.
    Chen Y; Brill GM; Benz NJ; Leanna MR; Dhaon MK; Rasmussen M; Zhou CC; Bruzek JA; Bellettini JR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):106-17. PubMed ID: 17826364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form.
    Sharma N; Rao SS; Reddy AM
    J Chromatogr Sci; 2012 Oct; 50(9):745-55. PubMed ID: 22562819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct high-performance liquid chromatography enantioseparation of terazosin on an immobilised polysaccharide-based chiral stationary phase under polar organic and reversed-phase conditions.
    Ferretti R; Gallinella B; La Torre F; Zanitti L; Turchetto L; Mosca A; Cirilli R
    J Chromatogr A; 2009 Jul; 1216(28):5385-90. PubMed ID: 19493532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of stability-indicating UHPLC method for the quantitative determination of silodosin and its related substances.
    Shaik JV; Saladi S; Sait SS
    J Chromatogr Sci; 2014 Aug; 52(7):646-53. PubMed ID: 23845884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a simple and stability-indicating RP-HPLC method for determining olanzapine and related impurities generated in the preparative process.
    Cui D; Li Y; Lian M; Yang F; Meng Q
    Analyst; 2011 Aug; 136(15):3149-56. PubMed ID: 21695344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation, structure characterization and quantification of related impurities in asperosaponin VI.
    Ji D; Liu YF; Wang QH; Zhang CF; Yang ZL
    Chin J Nat Med; 2013 Jul; 11(4):419-26. PubMed ID: 23845554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous Determination of Impurities of Atazanavir and Ritonavir in Tablet Dosage Form by Using Reversed-Phase Ultra Performance Liquid Chromatographic Method.
    Mantripragada MKVVN; Rao SV; Nutulapati VVS; Mantena BPV
    J Chromatogr Sci; 2018 Mar; 56(3):270-284. PubMed ID: 29300835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A stability indicating simultaneous dual wavelength UV-HPLC method for the determination of potential impurities in fampridine active pharmaceutical ingredient.
    Thomas S; Shandilya S; Bharti A; Agarwal A
    J Pharm Biomed Anal; 2012 Jan; 58():136-40. PubMed ID: 22000073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-performance liquid chromatographic enantioseparation of aminonaphthol analogs on polysaccharide-based chiral stationary phases.
    Ilisz I; Pataj Z; Berkecz R; Szatmári I; Fülöp F; Péter A
    J Chromatogr A; 2010 Apr; 1217(17):2980-5. PubMed ID: 20236648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemometrically assissted optimization and validation of RP-HPLC method for the analysis of itraconazole and its impurities.
    Kasagić I; Malenović A; Jovanović M; Rakić T; Jančić Stojanović B; Ivanović D
    Acta Pharm; 2013 Jun; 63(2):159-73. PubMed ID: 23846140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous separation and determination of coenzyme Q(10) and its process related impurities by NARP-HPLC and atmospheric pressure chemical ionization-mass spectrometry (APCI-MS).
    Nageswara Rao R; Kumar Talluri MV; Shinde DD
    J Pharm Biomed Anal; 2008 Jun; 47(2):230-7. PubMed ID: 18243624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impurity Profiling and Identification of 2,6-Diisopropylphenol by HPLC Method and Raman Spectroscopy Method.
    Swathi K; Uma Maheshwari P; Nikitha B; Sara L
    Adv Exp Med Biol; 2021; 1339():273-282. PubMed ID: 35023115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a stability-indicating RP-LC method for the separation of a critical pair of impurities and their degradants in zafirlukast.
    Thiyagarajan TK; Abdul Hakeem JA; Baksam V
    J Chromatogr Sci; 2012; 50(10):945-52. PubMed ID: 22689905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of unknown impurities in cefotiam hexetil by HPLC-MS/MS].
    Tang QX; Liu MD; Yan YY; Ye Y; Wang ZH; Zhan LF; Liao LC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 May; 44(3):481-4, 493. PubMed ID: 23898540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and Validation of a RP-HPLC Method for Determination of Related Substances and Degradants in Entacapone.
    Purnachand D; Veerareddy A; Ramadevi B; Kameswarrao ChV; Madhusudhanreddy B
    J Chromatogr Sci; 2016 Sep; 54(8):1310-23. PubMed ID: 27165569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An improved liquid chromatographic method for the analysis of tylosin and its impurities.
    Ashenafi D; Hoogmartens J; Adams E
    J Sep Sci; 2011 Oct; 34(19):2631-8. PubMed ID: 21812113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel reverse phase stability indicating RP-UPLC method for the quantitative determination of fifteen related substances in Ranolazine drug substance and drug product.
    Malati V; Reddy AR; Mukkanti K; Suryanarayana MV
    Talanta; 2012 Aug; 97():563-73. PubMed ID: 22841123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPTLC and RP-HPLC methods for simultaneous determination of Paracetamol and Pamabrom in presence of their potential impurities.
    Abdelaleem EA; Naguib IA; Hassan ES; Ali NW
    J Pharm Biomed Anal; 2015 Oct; 114():22-7. PubMed ID: 26001162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPLC method for simultaneous analysis of ticagrelor and its organic impurities and identification of two major photodegradation products.
    Bueno LM; Manoel JW; Giordani CF; Mendez AS; Volpato NM; Schapoval EE; Steppe M; Garcia CV
    Eur J Pharm Sci; 2017 Jan; 97():22-29. PubMed ID: 27816632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification, characterization and HPLC quantification of process-related impurities in Trelagliptin succinate bulk drug: Six identified as new compounds.
    Zhang H; Sun L; Zou L; Hui W; Liu L; Zou Q; Ouyang P
    J Pharm Biomed Anal; 2016 Sep; 128():18-27. PubMed ID: 27209451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.